Review confirms small cardiovascular risk with daily doses at or above 2,400 mg. The CMDh1 has endorsed by consensus updated advice on the use of high- dose ibuprofen. This follows a review carried out by EMA’s Pharmacovigilance Risk Assessment Committee (PRAC), which confirmed a...